source
- FDA launches rare disease framework initiativeA new initiative from the US Food and Drug Administration (FDA) aims to develop “an optimized, fit-for-purpose” framework to facilitate the development and marketing of treatments for rare diseases…raps · 5d ago↗ source
- Sanofi R&D chief urges Western pharma to factor China’s growing innovation into pipelinesSanofi’s newly appointed head of research and development said on Wednesday that Western pharmaceutical companies can no longer overlook China’s rapid progress in biopharma innovation. He noted th…
- Gilead invests up to $1.87 B in Vir Biotechnology for three T-cell engagers